Cg Oncology, Common Stock Pattern Recognition Three Outside Up or Down

CGON Stock   34.75  0.65  1.91%   
CG Oncology, pattern recognition tool provides the execution environment for running the Three Outside Up or Down recognition and other technical functions against CG Oncology,. CG Oncology, value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Three Outside Up or Down recognition function is designed to identify and follow existing trends. CG Oncology, momentum indicators are usually used to generate trading rules based on assumptions that CG Oncology, trends in prices tend to continue for long periods.

Recognition
The output start index for this execution was three with a total number of output elements of fifty-eight. The function generated a total of one valid pattern recognition events for the selected time horizon. The Three Outside Up/Down pattern helps to describe CG Oncology, Common bearish pattern that is followed by a black day whose close value is lower than the second day.

CG Oncology, Technical Analysis Modules

Most technical analysis of CG Oncology, help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CGON from various momentum indicators to cycle indicators. When you analyze CGON charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About CG Oncology, Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CG Oncology, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of CG Oncology, Common based on widely used predictive technical indicators. In general, we focus on analyzing CGON Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CG Oncology,'s daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of CG Oncology,'s intrinsic value. In addition to deriving basic predictive indicators for CG Oncology,, we also check how macroeconomic factors affect CG Oncology, price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2010 2022 2023 2024 (projected)
Days Sales Outstanding0.0705579.03164.61198.32
PTB Ratio61.5319.790.870.83
Hype
Prediction
LowEstimatedHigh
32.0134.7537.49
Details
Intrinsic
Valuation
LowRealHigh
31.2843.2846.02
Details
Naive
Forecast
LowNextHigh
32.0734.8137.55
Details
8 Analysts
Consensus
LowTargetHigh
62.0668.2075.70
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CG Oncology, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CG Oncology,'s short interest history, or implied volatility extrapolated from CG Oncology, options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Banking Idea
Banking
Invested over 40 shares
Blockchain Idea
Blockchain
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
When determining whether CG Oncology, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CG Oncology,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cg Oncology, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cg Oncology, Common Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CG Oncology, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CG Oncology,. If investors know CGON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CG Oncology, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(15.87)
Revenue Per Share
0.015
Quarterly Revenue Growth
3.778
Return On Assets
(0.16)
Return On Equity
(0.20)
The market value of CG Oncology, Common is measured differently than its book value, which is the value of CGON that is recorded on the company's balance sheet. Investors also form their own opinion of CG Oncology,'s value that differs from its market value or its book value, called intrinsic value, which is CG Oncology,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CG Oncology,'s market value can be influenced by many factors that don't directly affect CG Oncology,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CG Oncology,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CG Oncology, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CG Oncology,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.